Pennant Investors, LP Agios Pharmaceuticals, Inc. Transaction History
Pennant Investors, LP
- $367 Million
- Q2 2024
A detailed history of Pennant Investors, LP transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Pennant Investors, LP holds 15,100 shares of AGIO stock, worth $699,281. This represents 0.18% of its overall portfolio holdings.
Number of Shares
15,100
Previous 15,100
-0.0%
Holding current value
$699,281
Previous $441,000
47.62%
% of portfolio
0.18%
Previous 0.11%
Shares
1 transactions
Others Institutions Holding AGIO
# of Institutions
225Shares Held
56.2MCall Options Held
275KPut Options Held
251K-
Farallon Capital Management LLC San Francisco, CA5.65MShares$262 Million1.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.5MShares$255 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$225 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.88MShares$180 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.78MShares$129 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $2.54B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...